Twist Bioscience Corp’s filing revealed that its insider Cho Dennis unloaded Company’s shares for reported $4524.0 on Jul 02 ’25. In the deal valued at $36.19 per share,125 shares were sold. As a result of this transaction, Cho Dennis now holds 104,612 shares worth roughly $3.72 million.
Then, Finn Patrick John sold 209 shares, generating $7,564 in total proceeds. Upon selling the shares at $36.19, the President and COO now owns 240,574 shares.
Before that, Leproust Emily M. sold 476 shares. Twist Bioscience Corp shares valued at $17,228 were divested by the Chief Executive Officer at a price of $36.19 per share. As a result of the transaction, Leproust Emily M. now holds 645,306 shares, worth roughly $22.97 million.
Wolfe Research initiated its Twist Bioscience Corp [TWST] rating to an Outperform in a research note published on December 13, 2024; the price target was $60. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Goldman also remained covering TWST and has increased its forecast on January 17, 2024 with a “Buy” recommendation from previously “Neutral” rating. Berenberg started covering the stock on September 27, 2023. It rated TWST as “a Buy”.
Price Performance Review of TWST
On Monday, Twist Bioscience Corp [NASDAQ:TWST] saw its stock fall -6.76% to $35.59. Over the last five days, the stock has lost -0.95%. Twist Bioscience Corp shares have fallen nearly -24.79% since the year began. Nevertheless, the stocks have fallen -23.41% over the past one year. While a 52-week high of $60.90 was reached on 01/24/25, a 52-week low of $27.12 was recorded on 05/23/25.
Levels Of Support And Resistance For TWST Stock
The 24-hour chart illustrates a support level at 34.68, which if violated will result in even more drops to 33.78. On the upside, there is a resistance level at 37.25. A further resistance level may holdings at 38.91.
How much short interest is there in Twist Bioscience Corp?
A steep rise in short interest was recorded in Twist Bioscience Corp stocks on 2025-06-13, dropping by -0.31 million shares to a total of 10.31 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 10.62 million shares. There was a decline of -2.98%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 05, 2023 when Scotiabank began covering the stock and recommended ‘”a Sector outperform”‘ rating along with a $33 price target.
